Interstitial fibrosis and subsequent tubular atrophy are pivotal pathologic changes that lead to end-stage kidney disease (1) . Renal fibrosis is the end result of a series of events often initiated by the recruitment of monocytes from the circulation, their activation, and differentiation into macrophages. Macrophage activities are numerous and may include trophic effects (growth promoting, cellular differentiation, tissue repair, angiogenesis), cytotoxic tissue injury, and scavenging activities. Tubulointerstitial infiltration by macrophages is thought to play an active role in tissue fibrogenic reactions (1, 2) . Several molecules, including macrophage chemoattractant protein-1 (MCP-1), osteopontin, transforming growth factor-␤ (TGF-␤), RANTES, integrins, and the urokinase-plasmin cascade, have been implicated in the processes of macrophage adhesion and migration (3) . Myofibroblasts usually become the predominant interstitial cell type with chronic inflammation. These cells are considered to be the major source of the extracellular matrix components that accumulate during renal fibrosis. Myofibroblasts appear de novo in areas of future fibrosis in response to stimuli such as basic fibroblast growth factor, platelet-derived growth factor, TGF-␤1, metalloproteinase-2 (MMP-2), and plasminogen activator inhibitor-1 (PAI-1). Despite significant advances, knowledge about the regulation and function of macrophages and myofibroblasts during renal fibrosis remains incomplete, a fact that has hampered the development of effective therapy for patients with progressive renal disease.
A high-affinity cellular receptor for urokinase-type plasminogen activator (uPAR or CD87) has been identified on the plasma membrane of a variety of cell types, including monocytes, neutrophils, activated T cells, endothelial cells, glomerular epithelial and mesangial cells, tubular epithelial cells, fibroblasts, and myofibroblasts (4 -10) . First identified in 1985 (11) , uPAR is a highly glycosylated 50-kD to 60-kD protein.
Its currently known ligands are uPA, vitronectin, and kininogen (12) . uPAR itself lacks a transmembrane domain. It is anchored to the plasma membrane by a glycosyl phosphatidylinositol (GPI) moiety. Soluble forms also exist. Tubular uPAR immunoreactivity has been reported in normal human kidneys (10) . Changes in the pattern of uPAR expression have not yet been extensively investigated in renal disease. Increased renal production of uPAR has been reported in humans and mice with endotoxemia and in human kidneys with chronic pyelonephritis, acute tubular necrosis, and chronic allograft rejection (7, 8, 13, 14) .
It is now clear that uPAR is a multifunctional protein (15, 16, 17) . The glycolipid-anchored uPAR co-localizes pericellularly with components of the urokinase-plasmin activation system, including uPA and PAI-1, and endocytosis receptors such as members of the LDL receptor related protein (LRP) family. uPAR is frequently co-expressed with caveolin and members of the beta integrin superfamily (12) . The formation of functional units with these cellular proteins allows uPAR to generate cell surface concentrated proteolysis required for cell migration and also to contribute to non-proteolytic cellular adhesion by interacting with ␤2-leukocyte integrins or ␣v␤3 or ␣v␤5 integrins and vitronectin (18 -20) . Due to these cellular functions, uPAR is thought to regulate cellular responses during angiogenesis, inflammation, wound repair, and tumor metastasis (12, 19, 21, 22) . In addition to its ability to modulate cell migration, uPAR may mediate molecular crosstalk at cellular surfaces, cytoskeletal reorganization, endocytosis-dependent scavenging, and cellular apoptosis (12, 17, 23) .
Given these important functions for uPAR together with the observation that PAI-1 and uPA may be upregulated during renal fibrosis, the present study was designed to investigate the role of uPAR in the renal cellular response that follows ureteral obstruction. 
Materials and Methods

Animals and Experimental Protocol
UPAR-deficient (uPARϪ/Ϫ) and wild-type (uPARϩ/ϩ) mice on a C57BL/6 genetic background used for this study have been previously described (24) . Mice were bred in our animal facility and allowed to grow to a minimum weight of 20 g before the study began. The genotype of the mice was confirmed by Southern blot analysis of DNA extracted from tails. Five groups of gender-matched, agematched, and weight-matched uPARϪ/Ϫ and ϩ/ϩ mice were studied: 3 d after UUO (female, n ϭ 8 each), 7 d after UUO (male, n ϭ 8 each), 14 d after UUO (female, n ϭ 8 each), and 7 d after sham surgery (n ϭ 8 males and 8 females). UUO surgery was performed under general anesthesia. The left ureter was ligated with 4.0 silk at two separate locations in the UUO groups. Mice were killed by exsanguination under general anesthesia. All procedures were performed in compliance with the guidelines established by National Research Council Guide for the Care and Use of Laboratory Animals.
Kidney Tissue Preparation
Following exsanguination, the obstructed left kidney was harvested and the capsule removed. Day 3 and day 14 UUO and sham kidneys were processed for cryostat and microtome sectioning. The day 7 UUO kidneys and their sham controls were processed for protein and RNA extraction. Pieces to be embedded in paraffin were fixed in 10% buffered formalin, and those for cryostat sectioning were embedded in Tissue-Tek OCT compound (Sakura Finetek, Torrence, CA) and snap-frozen in pre-chilled 2-methylbutane. Tissues for protein and mRNA extraction were snap-frozen in liquid nitrogen and stored at Ϫ80°C for subsequent use. For protein isolation, frozen kidney tissue from each animal was individually ground into a fine powder using a pre-chilled mortar and pestle, homogenized in extraction buffer (0.05 M Tris, 0.01 M CaCl 2 , 2.0 M guanidine HCl, 0.2% Triton X-100, pH 7.5), and dialyzed using dialysis membrane Spectra/Por R 1 (Spectrum Medical Industries, Inc., Houston, Texas) against 0.05 M Tris, 0.2% Triton X-100, pH 7.5, for 48 h at 4°C. The samples were centrifuged for 5 min (14,000 ϫ g). The supernatant was aliquoted on the basis of the protein concentration measured using the Bradford protein assay (Bio-Rad, Hercules, CA). The aliquoted samples were stored at Ϫ80°C.
Northern Blot Analysis
Total kidney RNA was isolated by a modified phenol and guanidine isothiocyanate method using TRIzol reagent (Life Technologies BRL Life Technologies, Grand Island, NY) according to the manufacturer's instructions. Total kidney RNA (15 g) from each animal was separated by a 1% agarose formaldehyde gel electrophoresis. After a photomicrograph of the ethidium bromide-stained gel was obtained to evaluate RNA loading equality, the RNA was transferred to a hybridization membrane (GeneScreen Plus, New England Nuclear Life Science Products, Boston, MA) and fixed by ultraviolet cross-linking (UV Crosslinker, Hoeffer Scientific Instruments, San Francisco, CA). Complementary DNA probes for mouse uPAR1 (a 1.5-kb fragment), provided by Dr. Niels Behrendt, Finsen Laboratory, Copenhagen, Denmark (25) , rat osteopontin, provided by Dr. C. Giachelli, University of Washington, Seattle, WA (26) , and mouse MCP-1 provided by Dr. B. Rollins, Dana Farber Cancer Institute, Boston, MA (27) , were labeled with 32 P dCTP (3,000 Ci/mmol) by random priming with the T7 Quick Prime kit (Pharmacia Biotech, Piscataway, NJ). The membranes were hybridized with the radiolabeled cDNA probe using the QuickHyb hybridization solution (Stratagene, La Jolla, CA). Autoradiographs were developed and the density of each band quantified using the NIH Image program. The density of the 18 s ribosomal bands in the formaldehyde gels were used for RNA loading control.
Histologic Studies
Immunohistochemical studies were performed on frozen or paraffin-embedded renal tissue sections (4 m). Immunoperoxidase staining using ABC ELITE kits (Vector Laboratories Inc, Burlingame, CA) was performed on paraffin sections. Primary antibodies (Ab1) included anti-mouse uPAR (R&D Systems, Minneapolis, MN), rat anti-mouse F4/80, rat anti-mouse CD11b monoclonal antibodies (Serotec Ltd., Oxford, UK), goat anti-mouse MCP-1 (Santa Cruz Biotechnology, CA), anti-mouse osteopontin (Santa Cruz Biotechnology), horseradish peroxidase (HRP)-conjugated mouse anti-human smooth muscle actin (SMA) monoclonal antibody (DAKO Corp., Carpinteria, CA), HRP-conjugated mouse-anti-proliferating cell nuclear antigen (PCNA; DAKO), murine anti-mouse PAI-1 monoclonal antibody (MA-33H1F7, a generous gift from Dr. Declerck, Katholieke University, Belgium) (28) , and rat anti-mouse CD34 antibody (Pharmingen, San Diego, CA). For PAI-1 staining, Ab1 and Ab2 were pre-complexed before incubation with the tissue sections to minimize cross-reactivity between Ab2 and murine tissue IgG (29) . Cryosec- vitronectin, or PAI-1. ␣SMA and CD34 double-staining were performed with HRP-conjugated and alkaline phosphatase-conjugated secondary antibodies. Sections stained with Ab2 only were run in parallel as a negative control. The stained tubulointerstitial area was measured using a computerized image analysis system and Optimas software (Optimas version 6.5, Optimas Corp., Bothell, WA) as previously reported (31) . A point-counting method was used to quantify F4/80ϩ macrophage staining. Results were expressed as percentage of total measured tubulointerstitial area. CD11bϩ interstitial cells and PCNA-positive tubular and interstitial cells were counted manu- ally using an eyepiece grid and expressed as the percent positive tubulointerstitial cells as described previously (32) .
Western Blot Analysis
Protein samples (20 or 80 g) were separated by 10% SDS-PAGE). Proteins were transferred to a nitrocellulose membrane and the immunoreactive protein visualized using ECL-enhanced chemiluminescence (Amersham Pharmacia Biotech Inc., Piscataway, NJ). Ab1 used were rabbit anti-mouse CD14 antiserum (Santa Cruz Biotechnology), mouse anti-murine PAI-1 monoclonal antibody, HRP-conjugated mouse anti-PCNA monoclonal antibody, and HRP-conjugated mouse anti-human ␣-SMA monoclonal antibody. Ab2 were HRP-conjugated goat anti-rabbit IgG antiserum (Chemicon International Inc.) and HRP-conjugated goat anti-mouse IgG antiserum (Sigma Chemical Co.). For PAI-1 probing, Ab1 and Ab2 were premixed before incubation with the blots to block the crossreaction of Ab2 to tissue mouse IgG (29) . Ponceau S red or amido black staining of the blots was performed to determine loading equality
In Situ End Labeling of Apoptosis
Apoptotic cell nuclei were detected by in situ end labeling of endonuclease-cleaved DNA as described previously (33) . Briefly, sections were deparaffinized and stripped of proteins by incubation with 20 g/ml proteinase K in PBS at 37°C for 15 min. Endogenous peroxidase was inactivated by immersing the sections in 3% H 2 O 2 for 5 min. After pre-incubation with equilibration buffer, the samples were incubated with TdT in reaction buffer (containing bio-14-dUTP) at 37°C for 60 min. Rinsed with PBS, the tissue sections were stained with the ABC ELITE kit (Vector Lab. Inc.). Color was developed with AEC Substrates Chromogen (DAKO Corp.) and counterstained with hematoxylin. Negative controls were obtained by eliminating TdT in reaction buffer while other steps were run in parallel. Apoptotic tubulointerstitial cell nuclei were counted in 10 random cortical fields (ϫ400 magnification). Results were expressed as the number positive per 100 nuclei. For day 3 UUO kidneys, the number of apoptotic nuclei within tubular cross-sections and the interstitium were evaluated separately.
Interstitial Fibrosis Evaluated by Sirius Red Staining
Picrosirius red staining was performed to evaluate histologically the interstitial area occupied by collagen fibrils as described previously (31). Sections were examined by polarized light microscopy. Photographs of six random cortical fields (ϫ400) from each animal were taken using a SPOT camera and the percent positive tubulointerstitial area measured using the Optimas program.
Statistical Analyses
All data were expressed as mean Ϯ 1 SD unless otherwise stated. Results were analyzed by the Mann-Whitney U test or t test using the SPSS or Excel software. A P value Ͻ 0.05 was considered statistically significant.
Results
uPAR Genotype and Renal Expression
The genotypes of the experimental mice were confirmed by Southern blot analysis ( Figure 1A) . Northern blot analysis demonstrated undetectable uPAR message in the kidneys of uPARϪ/Ϫ mice and the sham uPARϩ/ϩ mice. In the kidneys of the uPARϩ/ϩ mice, uPAR mRNA was present 7 d after UUO ( Figure 1B) . uPAR immunohistochemical staining was negative on sham and all uPARϪ/Ϫ kidneys. In response to UUO, uPAR expression was detected on interstitial and tubular cells in the uPARϩ/ϩ kidneys (Figure 2 ).
Interstitial Macrophages and ␣v Integrin Expression
In response to UUO and compared with the sham-operated kidneys, the number of F4/80ϩ interstitial macrophages was significantly increased at 3 d only in the uPARϩ/ϩ mice; by day 14, the number of F4/80ϩ interstitial macrophages was significantly increased in the mice of both genotypes ( Figure  3) . However, at both time points, there were significantly fewer F4/80ϩ cells in the uPARϪ/Ϫ mice compared with the ϩ/ϩ mice. This difference in the number of renal macrophages was reconfirmed when CD11bϩ interstitial cells were counted ( Figure 4 ). Western blot analysis for CD14, another murine monocyte/macrophage antigen, on day 7, also showed that CD14 protein levels were 1.5-fold higher in uPARϩ/ϩ mice (1.00 Ϯ 0.11 versus 0.63 Ϯ 0.02 arbitrary units).
Given that previous studies have suggested that uPAR may interact with ␣v␤3 and ␣v␤5 integrin receptors to facilitate leukocyte adhesion and migration, expression of the ␣v integrin chain was examined (18, 19, 22) . In the ϩ/ϩ mice ␣v integrin was expressed at low levels on a few cortical tubules in the sham control kidneys. ␣v protein was increased tenfold in the day 14 UUO group, but its expression was primarily restricted to tubules ( Figure 5 ). Although tubular expression of ␣v integrin also increased in uPARϪ/Ϫ mice during UUO, this adhesive molecule was expressed at a significantly lower level in uPARϪ/Ϫ mice on days 14 UUO compared with ϩ/ϩ mice.
Several chemoattractant molecules are also known to participate in renal monocyte recruitment triggered by ureteral obstruction such as monocyte chemoattractant protein-1 (MCP-1) and osteopontin. In response to 7 d of UUO, renal MCP-1and osteopontin mRNA levels were significantly increased, but only osteopontin expression was attenuated in the uPARϪ/Ϫ mice compared with uPARϩ/ϩ mice (Figures 6  and 7) . In fact, MCP-1 levels were higher in the uPARϪ/Ϫ mice on day 7. Western blot analysis reconfirmed the difference in MCP-1 expression between the uPARϩ/ϩ and Ϫ/Ϫ mice ( Figure 6 ). Immunostaining of the obstructed kidneys detected MCP-1 protein mainly in renal tubules but some interstitial reactivity was also present. Osteopontin expression in the UUO kidneys was limited to a subpopulation of renal tubules, and the difference between the genotypes appeared to be due to greater tubular destruction in the uPARϪ/Ϫ mice, especially on day 14 when several of the osteopontin-positive cells appeared as tubular remnants within the interstitium (Figure 7) .
Interstitial Myofibroblasts and Capillaries
Smooth muscle cell-specific ␣ actin immunostaining was confined to the perivascular cells of the arterioles in sham groups of both genotypes. In response to UUO, the number of positive interstitial cells significantly increased with time, but the response was more intense in the uPARϪ/Ϫ mice ( Figure 8 ). The mean number of interstitial myofibroblasts was 1.8-fold and 2.1-fold higher in uPARϪ/Ϫ compared with the ϩ/ϩ mice on days 3 and 14 UUO, respectively. This difference between the two genotypes was reconfirmed on day 7 UUO by Western blot analysis that detected 2.4-fold more ␣-SMA protein in the kidneys of the uPARϪ/Ϫ mice (data not shown).
The interstitial cellular response to UUO was also characterized by increased angiogenesis, as defined by the density of CD34ϩ microvascular endothelial cells (34) . The degree of neovascularization was significantly greater in the uPARϪ/Ϫ group compared with the ϩ/ϩ group ( Figure 9 ). These CD34ϩ microvessels co-localized with ␣-SMA-positive interstitial myofibroblasts ( Figure 10 ). There was a significant positive correlation between the numerical values for the area of the tubulointerstitium stained for CD34 and ␣SMA (r ϭ 0.81; P Ͻ 0.05; Spearman rank correlation). 
Tubulointerstitial Cell Apoptosis and Proliferation
Apoptotic tubulointerstitial cells were rarely detected in sham kidneys of both genotypes, but the number increased with time following UUO (Figure 11 ). uPAR deficiency resulted in the appearance of significantly more apoptotic tubular and interstitial cells on day 3 and day 14 UUO. Genotype also affected the proliferative response to injury. Using PCNA expression levels as an estimate of mitotic activity, Western blot studies indicated that proliferation was an early response to UUO (Figure 12) . However, at both 3 and 14 d, PCNA protein levels were significantly higher in the uPARϩ/ϩ kidneys compared with the uPARϪ/Ϫ kidneys. By semiquantitative immunohistochemistry it was determined that most PCNA-positive cells in the UUO kidneys were tubular epithelial cells although rare positive interstitial cells were also detected ( Figure 12 ).
Accumulation of Vitronectin and PAI-1
Vitronectin, a PAI-1-binding extracellular matrix protein that is a ligand of ␣v␤3 and ␣v␤5 integrins (18, 19) , was restricted to the vasculature and glomeruli in the sham-operated kidneys. After UUO, vitronectin was deposited within atrophic tubules and the interstitium to a greater extent in the uPARϪ/Ϫ mice compared with ϩ/ϩ mice ( Figure 13) . By immunostaining PAI-1 protein, not detected in the sham kidney, accumulated in interstitial areas, often co-localizing with ␣-SMA-positive cells (Figure 14) . Western blot analysis demonstrated significantly more PAI-1 protein (1.5-fold increased) in uPARϪ/Ϫ compared with ϩ/ϩ kidneys on days 7 after UUO ( Figure 15 ).
Interstitial Fibrosis
Sirius red staining showed an impressive increase in interstitial collagen fibrils after UUO, reaching a tenfold increase in the uPAR-deficient mice by 14 d (Figure 16 ). The Sirius red-positive interstitial area was significantly less in the uPARϩ/ϩ mice compared with the Ϫ/Ϫ mice after 14 d of ureteral obstruction.
Discussion
The results of this study indicate that the urokinase receptor serves to dampen the severity of the renal fibrogenic response that is initiated by ureteral obstruction. In this experimental model, we have previously reported that renal uPA gene expression and enzyme activity are significantly increased (35) . From the present study, it is evident that uPAR plays a pivotal role in the regulation of the cellular responses to ureteral obstruction but that its role is highly cell specific. Cells of multiple lineages may express uPAR including resident kidney cells (epithelial, mesangial, and endothelial), inflammatory cells (monocytes, activated T cells, and neutrophils), and fibroblasts/myofibroblasts. In response to ureteral obstruction, renal uPAR gene expression was significantly upregulated. The uPAR protein was identified on both interstitial cells and renal tubules in wild-type kidneys after UUO. The expression of uPAR in these regions of the kidney coupled with significant differences in the number of interstitial monocytes, myofibroblasts, and interstitial endothelial cells in uPAR wild-type mice compared with uPAR null mice suggests that recruitment and perhaps function of these cells are modulated by uPAR.
Monocytes and macrophages that pervade the interstitium of chronically damaged kidneys are thought to be one of the mediators of fibrosis due their ability to synthesize several pro-fibrotic molecules (36) . The present study is one of the first to demonstrate that the phenotype of the inflammatory renal interstitial cells is a critical factor that determines whether the macrophages function primarily as scavengers to minimize injury or as villains that perpetrate damage. In the absence of uPAR, not only is interstitial macrophage recruitment impaired, but the absence of this "scavenging" receptor appears to delay the clearance of molecules that promote fibrosis. Although many molecules may be involved, our data suggest that delayed clearance of PAI-1 and perhaps apoptotic cells by uPAR-bearing cells may contribute to a more aggressive fibrotic response. In addition to several in vitro studies docu- menting a role for uPAR in cellular movement, impaired migration of tumor cells and neutrophils has also been reported in uPAR-deficient mice (22, 37) . In the mouse model of bleomycin-induced lung fibrosis, delayed macrophage recruitment has also been observed in uPAR-deficient mice (38) . The findings in the present study of significantly fewer renal macrophages in uPARϪ/Ϫ mice contrasts with the results of an earlier study of acute crescentic glomerulonephritis that demonstrated that neither uPAR nor uPA-deficiency modified the severity of glomerular inflammation or renal dysfunction, possibly because increased uPA is not a significant feature in that model of acute glomerular injury (39) . The increased number of interstitial mononuclear cells in chronically damaged kidneys is thought to be the consequence of the migration of circulating monocytes into the interstitium although limited in situ proliferation of resident interstitial macrophages may also occur (40) . In the present study, most of the PCNAϩ cells were tubular cells, and a difference in the number of positive interstitial cells was relatively small but significant. Whether the proliferating cells were macrophages or myofibroblasts was not determined. Urokinase is known to play a role in cell migration due to its ability to facilitate cell-cell and cell-matrix interactions. UPAR is known to associate with the leukocyte integrin CD11b/CD18 and L-selectin to regulate leukocyte migration and cellular signaling (20, 41, 42) . In addition, the uPA-uPAR complex physically cooperates with certain members of the integrin superfamily including ␣v␤5 and ␣v␤3 to direct cell adhesion to and migration along vitronectin (18, 19, 43) . Co-clustering and resonance energy transfer between uPAR and ␣v␤5 or ␣v␤3 integrins has been observed to transduce migratory signals to cells adherent to vitronectin (44) . In addition to serving as an inte- grin-associated protein, the cell surface glycolipid-anchored uPAR may also serve as an integrin ligand, thereby mediating direct contact with adjacent cells (45) . In the present study, expression of the ␣v integrin chain was enhanced in response to UUO but it was most abundant on tubular cells. Expression of the ␣v integrin chain by tubular cells was attenuated in the uPAR-deficient mice at 14 d, perhaps an indication that, like the leukocyte integrin CD11b/CD18, clustering of uPAR may induce ␣v integrin expression (46) or that the two receptors are coordinately expressed (19) .
Furthermore, uPA may cleave its receptor to release soluble uPAR, a molecule with monocyte chemoattractant properties (47) . It has recently been reported that this chemotactic response is triggered by interactions of soluble uPAR with the FPRL1/LXA4 receptor (formyl-methionyl-leucyl-leucyl-proline[fMLP]-like receptor-1/lipoxin A4 receptor) (48) . Additional studies will be necessary to determine if uPAR-integrin and/or soluble uPAR-FPRL1/LXA4 receptor interactions fully explain why the interstitial recruitment of uPAR-deficient monocytes is impaired in obstructive uropathy. Several chemokines and adhesion molecules have been implicated in the genesis of the interstitial inflammatory response to obstruction, including MCP-1 (49) and osteopontin (50) . We cannot eliminate the possibility that the lower levels of osteopontin observed in the uPARϪ/Ϫ mice also contributed to the blunted inflammatory response. In fact, osteopontin-induced cell migration may be dependent on uPA-uPAR activity (51) .
Despite the fact that uPAR deficiency dampened the intensity of the interstitial inflammatory response to obstruction, the severity of fibrosis was worse in the uPAR-deficient mice. This outcome is likely due to the more aggressive myofibroblastic response that developed in the uPAR-deficient mice. The development of a myofibroblastic phenotype in the renal interstitium has been highly predictive of renal functional deterioration due to fibrosis (52) (53) (54) . Myofibroblasts are currently considered to be a major source of the matrix proteins that accumulate in the kidney during fibrosis. The specific cellular origin of interstitial myofibroblasts remains controversial but possibilities included transformed resident interstitial fibroblasts, transdifferentiated tubular epithelial cells, migratory vascular cells and pericytes cells, circulating mesenchymal precursor cells, and perhaps even transformed monocytic cells (3, 55) . Given the unknown origin of the interstitial myofibroblasts, it is impossible to determine if uPAR plays a direct role in promoting or impairing their migration. Our in vivo observations argue against differences in myofibroblast proliferation and/or apoptosis as an explanation but this possibility should be investigated more carefully in vitro. Of note is the in vivo observation that uPAR deficiency does not affect the migration of smooth muscle cells (56) . Our results also suggest the possibility that impaired "scavenging" activities in the uPAR null mice may have resulted in the appearance of significantly more myofibroblasts as a secondary consequence. Parallel genotype-dependent differences in the extent of interstitial angio- genesis, as defined by the number of cells expressing the endothelial antigen CD34, and the observed co-localization of regions of neovascularization with interstitial myofibroblasts suggest a significant relationship between these two processes. UPAR has been characterized as a scavenger receptor by virtue of its ability to work in collaboration with other scavenger receptors, especially the LDL receptor-related protein (LRP) to delete "unneeded" molecules by endocytosis (57) (58) (59) (60) . LRP-independent internalization of uPAR ligands has also been reported (61) . This endocytotic pathway is the primary route of elimination of extracellular PAI-1 (4, 62) . UPA and PAI-1 are subsequently degraded within lysosomes while uPAR is recycled to the cell surface. Significantly more PAI-1 accumulated in the kidneys of the uPARϪ/Ϫ mice after UUO. This finding, coupled with the fact that there was no difference in renal PAI-1 mRNA levels between uPAR-deficient and wild-type mice (63) , suggests a key role for uPAR in PAI-1 protein turnover in the kidney. The physiologic internalization of the urokinase-PAI-1 complex is triggered by the interaction of PAI-1 with a receptor belonging to the LRP family, and involves the formation of a macro-quaternary structure of uPAR, uPA, LRP, and PAI-1 (4). In addition, an alternative internalization process has also been described whereby uPAR acts as the anchoring structure on the plasma membrane and LRP subsequently works as the endocytic trigger (64).
Over-expression of PAI-1 is a feature of most progressive renal diseases (65) . We have recently reported that genetic PAI-1 deficiency resulted in significantly fewer interstitial myofibroblasts and decreased renal fibrosis in mice with obstructive nephropathy suggesting that the increased PAI-1 accumulation may be relevant to pathogenesis of the enhanced fibrosis that was observed in the uPAR null mice (35) . While decreased plasmin-dependent proteolysis may partially explain the pro-fibrotic effects of PAI-1 deficiency, PAI-1 may also regulate the migration of fibroblasts along vitronectin matrices. Vitronectin (or protein-S) is an adhesive protein that accumulates within extracellular matrices during the course of injury and repair (66, 67) . In addition to certain integrin receptors, including ␣v␤3, the classic vitronectin receptor, uPAR also has a vitronectin-binding site (30, 68) . Vitronectin, the primary PAI-1 binding protein, binds both uPAR-bound and matrixbound PAI-1. It has been suggested that vitronectin may function as a shuttle to facilitate PAI-1 transport to and phagocytosis by uPAR (66) . In the present study the extent of vitronectin accumulation in response to obstruction was greater in the kidneys of the uPAR null mice, suggesting that the delayed clearance of PAI-1 protein in these mice may be related to the absence of a functional vitronectin-uPAR pathway. While the mechanism that accounts for greater vitronectin accumulation cannot be addressed by this in vivo study, there Figure 17 . Schematic summary of the potential anti-fibrotic effects of uPAR. The uPAR binds both single-chain pro-urokinase and active two-chain uPA resulting in the generation of high pericellular proteolytic activity. Plasmin has multiple effects, including the activation of certain latent matrix-degrading metalloproteinases. Both uPA and uPAR exhibit direct monocyte chemoattractant properties. Although uPAR itself is anchored to the cell membrane via a glycosyl-phosphatidylinositol (GPI) moiety and lacks an intracellular domain, it frequently partners with a variety of integrin receptors to promote cellular adhesion to vitronectin matrices. In addition, the uPAR-integrin complexes may collaborate in the initiation of intracellular signaling reactions although the relevance of these effects to fibrosis remains unexplored. Through interactions with scavenger receptors such the LDL-receptor related protein (LRP) and the uPAR-associated protein (uPARAP), uPAR appears to facilitate endocytosis and degradation of pro-fibrotic molecules such as PAI-1.
are reasons to speculate that it may be an indirect consequence of uPAR deficiency. Vitronectin is endocytosed and degraded by the ␣v␤5 integrin receptor (69) . Not only does uPAR interact with ␣v␤5 integrin (18) , it is also possible that, like ␣v␤3, it may be coordinately expressed with uPAR (70) .
Increased PAI-1 accumulation may also be relevant to the differences in neovacularization observed between the uPAR wild-type and deficient mice. In a study of transplanted malignant keratinocytes, genetic PAI-1 deficiency was associated with a less robust angiogenic response, resulting in less extensive local tumor invasion (71) . Recent data suggest that the angiogenic effects of PAI-1 are dependent on its ability to inhibit proteolytic activity rather than due to its interactions with vitronectin and integrins (72) .
The uPAR may also modify the rate of renal cell death by apoptosis. Tubular cell apoptosis is currently considered to be a major pathway leading to tubular atrophy in progressive renal disease. In the present study, uPAR deficiency resulted in the appearance of significantly more apoptotic tubular cells; at the same time proliferation-dependent tubular cell regeneration was blunted. Cultured human glioma cells exposed to uPAR anti-sense have been reported to undergo more apoptotic cell death, an observation that was associated with upregulated expression of the pro-apoptotic gene BAX (23) . Interactions between uPAR and the ␣v␤3 integrin may also enhance cell survival via anti-apoptotic mechanisms (73) .
Changes in the cellular responses to ureteral obstruction were not the only differences observed in mice lacking uPAR. As predicted, renal plasminogen activator activity was significantly decreased despite similar renal mRNA levels of the plasminogen activators and their known inhibitors (63) .
In summary, uPAR plays an important role in directing changes in the cellular phenotype of tubulointerstitial cells that is associated with the fibrogenic response to ureteral obstruction. Our data suggest that uPAR deficiency impairs monocyte/ macrophage recruitment and diminishes scavenger receptor function resulting in delayed clearance of PAI-1 and vitronectin ( Figure 17) . As a consequence, ureteral obstruction induced in the absence of uPAR is characterized by a more intense myofibroblastic response, neovascularization, and tubular cell death resulting in more extensive renal destruction by fibrosis.
